GRHU previously announced the signing of multiple contract awards for its Life Protection (NYSE:LPI) Governmental Services Division, totaling $6 million. The recently acquired LPI subsidiary provides innovative training, support, design and construction of facilities and services to meet the needs of the U. S. Government, military, and law enforcement agencies.
The governmental contracting entities include the U.S. Marine Corps School of Dynamic Entry in Quantico, VA and the U.S. Army Schofield Barracks Range Support in Honolulu, HI. The combined value of these contracts totals $1.5 million and includes GreenHouse’s brand of Rapidly Assembled Portable Structures, (RAPS). In addition, to the governmental contracts, GreenHouse has signed contracts totaling $4.5 million for commercial projects, including a design-build contract for services ranging from project management and land planning to eco-friendly building products and services. GreenHouse expects the majority of the contracted work to be completed by year end 2010.
For more information about this company please visit http://www.greenhouseintl.com/
NetLogic Microsystems Inc. (NASDAQ:NETL) a worldwide leader in high performance intelligent semiconductor solutions for next-generation Internet networks, previously announced on October 28, 2010 financial results for its third quarter ended September 30, 2010. Revenue for the third quarter of 2010 was $100.1 million, a 5.3% sequential increase from $95.0 million for the second quarter of 2010 and a 136% increase from $42.3 million for the third quarter of 2009. Third quarter 2010 net income, determined in accordance with generally accepted accounting principles (GAAP), was $5.2 million or $0.08 per diluted share.
NetLogic Microsystems, Inc., a fabless semiconductor company, engages in the design, development, and sale of processors and integrated circuits.
Talecris Biotherapeutics Holdings Corp. (NASDAQ:TLCR) announced that the U.S. Food and Drug Administration (FDA) approved Gamunex®-C (Immune Globulin Injection [Human], 10% Caprylate/Chromatography Purified) for subcutaneous administration in the treatment of primary immunodeficiency (NASDAQ:PI).
The newly approved Gamunex-C provides both the intravenous route of administration and a new subcutaneous route of administration. The intravenous delivery mode is approved to treat PI, chronic inflammatory demyelinating polyneuropathy (CIDP), and idiopathic thrombocytopenic purpura (NYSEMKT:ITP). The subcutaneous mode is approved to treat only PI.
Talecris Biotherapeuticsis a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis.
Paychex Inc. (NASDAQ:PAYX) leading provider of payroll, human resource, and benefits outsourcing solutions for small- to medium-sized businesses, recently announced the promotion of a veteran senior manager in its sales and marketing organization. Neil Rohrer has been named vice president of sales for Core payroll in the Eastern United States. The Paychex Board of Directors has also appointed Rohrer a new officer of the company.
Rohrer most recently served as the company’s director of marketing. Prior to that, he was director of international business development, guiding Paychex’s expansion into Germany. Rohrer joined Paychex in 1986 as a sales representative, rising through the ranks to hold senior-level sales management positions.
Paychex, Inc., together with its subsidiaries, provides payroll, human resource, and benefits outsourcing solutions for small- to medium-sized businesses in the United States and Germany.
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more at http://crwepicks.com/disclaimer ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (GRHU). In addition to the cash, Crown Equity Holdings Inc. (OTCPK:CRWE) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party.